News

CPC LinkedIn: https://www.linkedin.com/company/cannabis-science-and-technology/posts/?feedView=all

CPC Facebook: https://www.facebook.com/CannSciTech

CPC Twitter: https://twitter.com/CannabisSciTech

CPC Instagram: https://www.instagram.com/cannabissciencetechnology/

CPC recently shared the article on its Cannabis Science and Technology platforms as part of its MedicalMonday series. The publisher noted, "The article seems to be getting a lot of love across the platforms!"

CPC LinkedIn: https://www.linkedin.com/company/cannabis-science-and-technology/posts/?feedView=all

CPC Facebook: https://www.facebook.com/CannSciTech

CPC Twitter: https://twitter.com/CannabisSciTech

CPC Instagram: https://www.instagram.com/cannabissciencetechnology/

Published on PE on December 21, 2022

Pe292 How Federal Legalization will Transform the Cannabis Industry

Join host Wayne Schwind and returning guest Ruth Fisher, PhD, as they dive into the hotly debated topic of federal legalization. With more States legalizing cannabis for recreational use, the pressure is on for the federal government to follow suit. What forces are driving federal legalization, and how will it impact businesses and States that have already legalized cannabis?

Chapters:

• 00:00 - Helpful regulations
• 04:35 - Taxing Medallions
• 08:55 - Interstate commerce regulations
• 13:50 - How rec. can complicate medical use
• 22:40 - Taxing across entire industry
• 25:00 - Potentcies affect on society + legalization
• 31:15 - Descheduling Vs. Rescheduling

Listen or watch below.

Join host Wayne Schwind and returning guest Ruth Fisher, PhD, as they discuss what the process of legalization has done to the cannabis industry. A complex problem exists in going from black market-only to a fully legal market. How can government successfully navigate this problem? What are different states doing, what's working, and what's not? What did we do when Prohibition was overturned?

Chapters:

• 00:00 - Intro, Ruth Fisher, Ph.D
• 01:00 - Taxing regulations impact on cannabis
• 05:50 - State-to-state regulated commerce
• 08:18 - Looking at cannabis tax procedures
• 16:30 - Why regulators tax this way
• 25:25 - Taming the black market

Listen or watch below.

The Medical Cannabis Primer by Ruth Fisher, Ph.D., is now $10 off its regular price, now just $28.95 on Amazon (rated 4.7 stars).

Are you confused by all the hype surrounding cannabis products? Addressing your medical problems with a hit-and-miss cannabis strategy won’t get predictable results.

The Medical Cannabis Primer is an excellent compendium of thousands of studies on the use of cannabis to treat medical problems. Authored by medical researcher Ruth Fisher, Ph.D., this compendium is loaded with real-world examples of how doctors currently prescribe cannabis to treat medical conditions. Get unbiased information, a chapter about contraindications, and another with “dos and don’ts” to ensure the highest likelihood of success.

The book is printed in full color and loaded with photos, charts, tables, and appendices, to help you best understand what you need to know. Whether you’re new to cannabis or a seasoned user, you’re guaranteed to learn something valuable about how to use it best to treat your medical symptoms.

For a limited time, our Medical Cannabis Fundamentals online class, designed to complement The Medical Cannabis Primer book, is available for just $19. This certificate class is suitable for professionals and enthusiasts who want that extra medical cannabis education. Check out teach.canndynamics.com for more information.

Dr. Fisher was interviewed by Madeline Colli of Cannabis Science and Technology magazine for an article posted on September 1 titled, Whole Plant Medicine Is the Future. For the interview, Dr. Fisher provides a brief overview of her accompanying analysis, Transitioning to 21st Century Medicine: The Promise of Whole Plant Medicine, and what she hoped to achieve by writing it. To this question, she replies,

But I think the current healthcare system is failing a lot of patients. As a game theorist and researcher, I’ve seen how the system has evolved, and I understand why it generates the outcomes it does. A good friend once told me that it’s useless for a consultant to tell someone they have a problem unless she can also tell that person how to fix the problem. My purpose for writing this article is to tell people what the problem is, why it exists, and how to fix it.

Dr. Fisher participated in a panel discussion at CBD Expo West in LA. In addition to Dr. Fisher, other panel participants included

• Host Keioko Beati, Director Of Education & Outreach at Coral Cove Wellness Resort Jamaica, Cannabis & Fungi Education for Wellness Speaker
• Co-panelist Chris Claussen, Chief Innovation Officer @ Leiio Wellness
• Co-panelist Peter Holzworth, Global Strategy Officer at BackBone IQ

Panelists discussed how the cannabis and psychedelics industry would evolve. Panelists agreed there’s tremendous potential for both industries to address health and wellness needs as well as provide recreational benefits. Also, while Mr. Holzworth stressed the need for standards, Dr. Fisher warned that standards should not be established prematurely, since anything put in place “just until we get more information” will invariably end up being difficult to change when the time comes.

The 2021 Virtual Cannabis Research Conference was held on August 3- 5. Dr. Fisher participated in a panel discussion that was hosted by Ruth Charbonneau, Associate Director, The Lambert Center for the Study of Medicinal Cannabis & Hemp.

The discussion was titled, “Law and Regulation and its Role in Cannabis Research.” 

Other Panelists included:

• Andrew Cole, Customized Audit Solutions and Compliance at BSI
• Deborah Miran, Consultant at DMiran Consulting, and Former Maryland Medical Cannabis Commissioner

The panelists discussed such issues as 

• How cannabis is unique relative to other agricultural and pharmaceutical products
• Why standards, consistency, and good manufacturing processes are important and how to bring them to the cannabis industry
• How to enable small providers and product variety to flourish in the industry